| P2093 | author name string | Philipp Markart | |
| | Richard Schulz | |
| | Hans-Joachim Eisele | |
| P2860 | cites work | Obstructive sleep apnea and dyslipidemia: evidence and underlying mechanism | Q26999248 |
| | Oxidative stress: a concept in redox biology and medicine | Q27022650 |
| | High prevalence of unrecognized sleep apnoea in drug-resistant hypertension | Q28207857 |
| | The occurrence of sleep-disordered breathing among middle-aged adults | Q29547889 |
| | Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study | Q29615583 |
| | Cyclical variation of the heart rate in sleep apnoea syndrome. Mechanisms, and usefulness of 24 h electrocardiography as a screening technique | Q30463055 |
| | Cardiovascular and psychiatric morbidity in obstructive sleep apnea (OSA) with insomnia (sleep apnea plus) versus obstructive sleep apnea without insomnia: a case-control study from a Nationally Representative US sample | Q31153185 |
| | The isoprostanes--25 years later | Q33601352 |
| | Nitric oxide biosynthesis, nitric oxide synthase inhibitors and arginase competition for L-arginine utilization | Q33731987 |
| | Inflammation, oxidative stress, and repair capacity of the vascular endothelium in obstructive sleep apnea | Q33748662 |
| | Sleep duration predicts cardiovascular outcomes: a systematic review and meta-analysis of prospective studies | Q33814169 |
| | Enzymatic function of nitric oxide synthases | Q33847576 |
| | Reversal of obstructive sleep apnoea by continuous positive airway pressure applied through the nares | Q34054705 |
| | Increased adhesion molecules expression and production of reactive oxygen species in leukocytes of sleep apnea patients | Q34122262 |
| | Epidemiology of obstructive sleep apnea: a population health perspective | Q34126856 |
| | Attenuated endothelium-dependent vascular relaxation in patients with sleep apnoea. | Q51016248 |
| | Peroxynitrite, a cloaked oxidant formed by nitric oxide and superoxide | Q67509483 |
| | Antioxidant vitamin C improves endothelial function in obstructive sleep apnea | Q46913805 |
| | Circulating nitric oxide (NO), asymmetric dimethylarginine (ADMA), homocysteine, and oxidative status in obstructive sleep apnea-hypopnea syndrome (OSAHS). | Q46961664 |
| | Lipid peroxidation and protein oxidation are related to the severity of OSAS. | Q48003931 |
| | Advanced oxidation protein products and ischaemia-modified albumin in obstructive sleep apnea | Q48029956 |
| | DNA damage in peripheral blood lymphocytes from patients with OSAHS. | Q48129248 |
| | Cardiovascular mortality in obstructive sleep apnea in the elderly: role of long-term continuous positive airway pressure treatment: a prospective observational study. | Q48222593 |
| | Sleep-disordered breathing in deep vein thrombosis and acute pulmonary embolism | Q48256895 |
| | Cardiovascular mortality in women with obstructive sleep apnea with or without continuous positive airway pressure treatment: a cohort study | Q48264033 |
| | Microvascular endothelial dysfunction in obstructive sleep apnea is caused by oxidative stress and improved by continuous positive airway pressure therapy | Q48317433 |
| | Total antioxidant status in patients with obstructive sleep apnea without comorbidities: the role of the severity of the disease. | Q48319852 |
| | Obstructive sleep apnea in patients with abdominal aortic aneurysms: highly prevalent and associated with aneurysm expansion | Q48349872 |
| | Masked hypertension in obstructive sleep apnea syndrome | Q48438013 |
| | Allopurinol improves endothelial function in sleep apnoea: a randomised controlled study | Q48500312 |
| | Antioxidant status in patients with sleep apnoea and impact of continuous positive airway pressure treatment | Q48506319 |
| | Activation of nuclear factor kappaB in obstructive sleep apnea: a pathway leading to systemic inflammation | Q48512187 |
| | Changes in extracranial arteries in obstructive sleep apnoea | Q48567181 |
| | Endothelial Function in Obstructive Sleep Apnea and Response to Treatment | Q48616765 |
| | Serum levels of vascular endothelial growth factor are elevated in patients with obstructive sleep apnea and severe nighttime hypoxia | Q48673745 |
| | Circulating nitric oxide is suppressed in obstructive sleep apnea and is reversed by nasal continuous positive airway pressure. | Q48708402 |
| | Abnormal lipid peroxidation in patients with sleep apnoea | Q48708654 |
| | Enhanced release of superoxide from polymorphonuclear neutrophils in obstructive sleep apnea. Impact of continuous positive airway pressure therapy | Q48716348 |
| | Daytime pulmonary hemodynamics in patients with obstructive sleep apnea without lung disease | Q48764914 |
| | Effects of obstructive sleep apnea on endothelin-1 and blood pressure. | Q48768740 |
| | Spontaneous platelet activation and aggregation during obstructive sleep apnea and its response to therapy with nasal continuous positive airway pressure. A preliminary investigation | Q48806749 |
| | Can mitochondrial dysfunction be a predictive factor for oxidative stress in patients with obstructive sleep apnea? | Q34154538 |
| | Vascular endothelial dysfunction: does tetrahydrobiopterin play a role? | Q34341995 |
| | Oxidative stress mediated arterial dysfunction in patients with obstructive sleep apnoea and the effect of continuous positive airway pressure treatment | Q34348192 |
| | Insomnia and risk of cardiovascular disease: a meta-analysis | Q34401455 |
| | Endothelial dysfunction in the microcirculation of patients with obstructive sleep apnea | Q34535079 |
| | Endothelial nitric oxide synthase uncoupling: a novel pathway in OSA induced vascular endothelial dysfunction | Q34980336 |
| | Pulmonary haemodynamics in obstructive sleep apnoea. | Q35046790 |
| | Decreased plasma levels of nitric oxide derivatives in obstructive sleep apnoea: response to CPAP therapy | Q35533588 |
| | Sympathetic neural mechanisms in obstructive sleep apnea. | Q35764596 |
| | Sympatho-adrenal activation by chronic intermittent hypoxia | Q36320908 |
| | A pathway-based analysis on the effects of obstructive sleep apnea in modulating visceral fat transcriptome. | Q36473127 |
| | Role of respiratory control mechanisms in the pathogenesis of obstructive sleep disorders | Q37267023 |
| | Obstructive sleep apnea and the risk of sudden cardiac death: a longitudinal study of 10,701 adults | Q37364043 |
| | Arginase activity and nitric oxide levels in patients with obstructive sleep apnea syndrome | Q37676877 |
| | Non-dipping pattern of hypertension and obstructive sleep apnea syndrome. | Q37785487 |
| | The biology and therapeutic potential of the DDAH/ADMA pathway. | Q37830082 |
| | Effects of obstructive sleep apnoea on heart rhythm | Q38069138 |
| | Obstructive sleep apnea, oxidative stress and cardiovascular disease: lessons from animal studies | Q38093579 |
| | Obstructive sleep apnoea in adult indigenous populations in high-income countries: an integrative review | Q38236105 |
| | Microarray studies of genomic oxidative stress and cell cycle responses in obstructive sleep apnea. | Q38301607 |
| | Endothelial dysfunction and oxidative stress in children with sleep disordered breathing: role of NADPH oxidase | Q38414359 |
| | Endothelial function and circulating endothelial progenitor cells in patients with sleep apnea syndrome | Q40166547 |
| | The role of nitric oxide and other endothelium-derived vasoactive substances in vascular disease | Q40418229 |
| | Cyclic GMP as a Second Messenger in the Cardiovascular System | Q40435187 |
| | Free radicals, antioxidants, and human disease: curiosity, cause, or consequence? | Q40625534 |
| | The role of oxygen radicals in human disease, with particular reference to the vascular system | Q40908762 |
| | Arterial hypertension in a murine model of sleep apnea: role of NADPH oxidase 2. | Q42239472 |
| | Association of urinary 15-F2t-isoprostane level with oxygen desaturation and carotid intima-media thickness in nonobese sleep apnea patients | Q43212782 |
| | Evidence for lipid peroxidation in obstructive sleep apnea | Q43800410 |
| | Obstructive sleep apnea is independently associated with insulin resistance. | Q43903080 |
| | Effects of CPAP on oxidative stress and nitrate efficiency in sleep apnoea: a randomised trial. | Q44117488 |
| | 8-Isoprostane, a marker of oxidative stress, is increased in exhaled breath condensate of patients with obstructive sleep apnea after night and is reduced by continuous positive airway pressure therapy. | Q44615125 |
| | Antioxidant capacity in obstructive sleep apnea patients | Q44638536 |
| | Levels of TBARS are inversely associated with lowest oxygen saturation in obese patients with OSAS. | Q45158278 |
| | Amelioration of vascular endothelial dysfunction in obstructive sleep apnea syndrome by nasal continuous positive airway pressure--possible involvement of nitric oxide and asymmetric NG, NG-dimethylarginine | Q45238935 |
| | Relationship between reduced nicotinamide adenine dinucleotide phosphate oxidase subunit p22phox gene polymorphism and obstructive sleep apnea-hypopnea syndrome in the Chinese Han population. | Q45945914 |
| | The impact of the sleep apnea syndrome on oxidant-antioxidant balance in the blood of overweight and obese patients. | Q46121404 |
| | Oxidative stress markers in the blood of persons with different stages of obstructive sleep apnea syndrome. | Q46121439 |
| | Increased plasma levels of asymmetric dimethylarginine and soluble CD40 ligand in patients with sleep apnea | Q46301695 |
| | Oxidative stress in obstructive sleep apnea | Q46486224 |
| | Oxidative stress in obstructive sleep apnoea | Q46654980 |
| | Impairment of serum albumin antioxidant properties in obstructive sleep apnoea syndrome. | Q46767891 |
| P275 | copyright license | Creative Commons Attribution 3.0 Unported | Q14947546 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | cardiovascular disease | Q389735 |
| | obstructive sleep apnea | Q16606552 |
| | physiological phenomenon | Q66615932 |
| P5008 | on focus list of Wikimedia project | ScienceSource | Q55439927 |
| P304 | page(s) | 608438 | |
| P577 | publication date | 2015-06-08 | |
| P1433 | published in | Oxidative medicine and cellular longevity | Q26840015 |
| P1476 | title | Obstructive Sleep Apnea, Oxidative Stress, and Cardiovascular Disease: Evidence from Human Studies | |
| P478 | volume | 2015 | |